You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

LUPANETA PACK Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Lupaneta Pack patents expire, and when can generic versions of Lupaneta Pack launch?

Lupaneta Pack is a drug marketed by Abbvie Endocrine and is included in one NDA.

The generic ingredient in LUPANETA PACK is leuprolide acetate; norethindrone acetate. There are twenty-two drug master file entries for this compound. Additional details are available on the leuprolide acetate; norethindrone acetate profile page.

Summary for LUPANETA PACK
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 1
Patent Applications: 1
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in LUPANETA PACK?LUPANETA PACK excipients list
DailyMed Link:LUPANETA PACK at DailyMed
Drug patent expirations by year for LUPANETA PACK

US Patents and Regulatory Information for LUPANETA PACK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie Endocrine LUPANETA PACK leuprolide acetate; norethindrone acetate INJECTABLE, TABLET;INTRAMUSCULAR, ORAL 203696-001 Dec 14, 2012 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie Endocrine LUPANETA PACK leuprolide acetate; norethindrone acetate INJECTABLE, TABLET;INTRAMUSCULAR, ORAL 203696-002 Dec 14, 2012 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LUPANETA PACK

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie Endocrine LUPANETA PACK leuprolide acetate; norethindrone acetate INJECTABLE, TABLET;INTRAMUSCULAR, ORAL 203696-001 Dec 14, 2012 ⤷  Try a Trial ⤷  Try a Trial
Abbvie Endocrine LUPANETA PACK leuprolide acetate; norethindrone acetate INJECTABLE, TABLET;INTRAMUSCULAR, ORAL 203696-002 Dec 14, 2012 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for LUPANETA PACK

See the table below for patents covering LUPANETA PACK around the world.

Country Patent Number Title Estimated Expiration
Japan 4988660 ⤷  Try a Trial
Denmark 1142567 ⤷  Try a Trial
Austria 219662 ⤷  Try a Trial
Spain 2249362 ⤷  Try a Trial
European Patent Office 0779072 Production de microsphères (Production of microspheres) ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.